Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice

Journal of Investigative Dermatology

Volumn 114, Issue 5, 2000, Pages 976-983

  Schön, Margarete ^a   Denzer, Dirk ^b   Kubitza, Robert C ^a   Ruzicka, Thomas ^a   Schön, Michael P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BAYER AG   (Germany)

Author keywords

Epidermal microabscesses; Flaky skin; Neutrophils; Psoriasis

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS;

EID: 0034070974     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00953.x     Document Type: Article

References (57)

1. Arnaout MA, Wang EA, Clark SC, Sieff CA: Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest 78:597-601, 1986
2. Baggiolini M, Walz A, Kunkel SL: Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989
3. Barszcz D, Zarebska Z, Glinska-Ferenz M, Jablonska S, Tigalonowa M, Glinski W: Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare. Arch Dermatol Res 280:198-206, 1988
4. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD: Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nature Med 4:615-618, 1998
5. Bosma MJ, Carroll AM: The SCID mouse mutant: definition, characterization, and potential uses. Ann Rev Immunol 9:323-350, 1991
6. Bradley PP, Priebat DA, Christensen RD, Rothstein GJ: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209, 1982
7. Brain SD, Camp RDR, Dawd PM: Leukotriene B4 and monohydroxyeicosatetraeonoic acid like material are released in biologically active amounts from the lesional skin of patients with psoriasis. Br J Pharmacol 83:313-317, 1983
8. Bussolino F, Wang JM, Defilippi P, et al: Granulocyte-and granulocyte macrophage colony-stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337:471-473, 1989
9. Camp R, Russell JR, Brain S, Woolard P, Greaves M: Production of intraepidermal microabscesses by topical application of leukotriene B4. J Invest Dermatol 82:202-204, 1984
10. Camp RDR: Polypeptide neutrophil chemoattractants in the skin. Dermatologica 179:20s-24s, 1989
11. Camp RDR, Bacon KB, Fincham NJ: Lymphocyte chemoattractants in psoriasis and normal skin. J Invest Dermatol 95:22s-23s, 1990
12. Carroll JM, Romero MR, Watt FM: Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83:957-968, 1995
13. Chertov O, Michiel DF, Xu L, et al: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271:2935-2940, 1996
14. Chertov O, Ueda H, Xu LL, et al: Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 186:739-747, 1997
15. Christophers E, Sterry W: Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in General Medicine. New York: McGraw-Hill, 1993, pp. 489-514
16. Clark SC, Kamen R: The human hematopoietic colony-stimulating factors. Science 236:1229-1237, 1987
17. 2-terminal sequence-characterised human monokine possessing neutrophil chemotactic, skin reactive, and granulocytosis-promoting activity. J Exp Med 167:1364-1376, 1988
18. Das PK, de Boer OJ, Visser A, Verhagen CE, Bos JD, Pals ST: Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Derm Venereol Supplementum 186:21-22, 1994
19. Detmar M, Tenorio S, Hettmannsperger U, Ruszczak Z, Orfanos CE: Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 98:147-153, 1992
20. Gasson JC, Weisbart RH, Kaufman SE, Clark SC, Hewick RM, Wong GG, Golde DW: Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 226:1339, 1984
21. Gillitzer R, Ritter U, Spandau U, Goebeler M, Bröcker EB: Differential expression of GRO-alphn and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation. J Invest Dermatol 107:778-782, 1996
22. Glinski W, Barszcz D, Janczura E, Zarebska Z, Jablonska S: Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity. Br J Dermatol 111: 481-487, 1984
23. Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation of recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
24. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human b2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112, 1990
25. Hemler ME: VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Ann Rev Immunol 8:365-400, 1990
26. van de Kerkhof PCM, Chang A: Migration of polymorphonuclear leukocytes in psoriasis. Skin Pharmacol 2:138-154, 1989
27. van de Kerkhof PCM, Lammers AM: Intraepidermal accumulation of polymorphonuclear leukocytes in chronic stable plaque psoriasis. Dermatologica 174:224-227, 1987
28. Kragballe K, Desjarlais L, Vorhees JJ: Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br J Dermatol 113:43-52, 1985
29. Kuijpers AL, Zeeuwen PL, de Jongh GJ, van de Kerkhof PC, Alkernade HA, Schalkwijk J: Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation: Arch Dermatol Res 288:641-647, 1996
30. Lu H, Smith CW, Perrard J, et al: LFA-1 is sufficient in mediating neutrophil emigration in Mac-1 deficient mice. J Clin Invest 99:1340-1350, 1997
31. Ludolph-Hauser D, Schubert C, Wiedow O: Structural changes of human epidermis induced by human leukocyte-derived proteases. Exp Dermatol 8:46-52, 1999
32. Mainardi CL, Dixit SN, Kang AH: Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem 255:5435-5441, 1980
33. Mallet AI, Cunningham FM, Daniel R: Rapid isocratic high performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin. J Chromatogr 309:160-164, 1984
34. Nanney LB, Sundberg JP, King LE: Increased epidermal growth factor receptor in fsn/fsn mice. J Invest Dermatol 106:1169-1174, 1996
35. Nibbering PH, Thio B, Zomerdijk TP, Bezemer AC, Beijersbergen RL, van Furth R: Effects of monomethylfumarate on human granulocytes. J Invest Dermatol 101:37-42, 1993
36. O'Flaherty JT, Rossi AG, Redman J, Jacobsen DP: Tumor necrosis factor alpha regulates expression of receptors for formyl-methiony-leucyl-phenylalanma, leukotriene B4, and platelet activating factor. Dissociation from priming in human polymorphonuclear neutrophils. J Immunol 147:3842-3847, 1991
37. Pelsue SC, Schweitzer PA Schweitzer IB, et al: Lymphadenopathy, elevated serum IgE levels, autoimmunity, and mast cell accumulation in flaky skin mutant mice. Eur J Immunol 28:1379-1388, 1998
38. Pigatto PD, Radaelli A, Tadini G, Polenghi MM, Brambilla L, Altomare G, Carandente F: Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients. Arch Dermatol Res 277:185-189, 1985
39. Pinkus H, Mehregan AH: The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol 46:109-116, 1966
40. Ristow HJ: Stimulation of DNA synthesis in cultured mouse epidermal cells by human peripheral leukocytes. J Invest Dermatol 79:408-411, 1982
41. Schön MP, Detmar M, Parker CM: Murine psoriasis-like disorder induced by naive CD4+ T-cells. Nature Med 3:183-188, 1997
42. Schröder JM, Mrowietz U, Morita E, Christophers E: Purification and partial biochemical characterisation of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin-1 activity. J Immunol 139:3474-3483, 1987
43. Schröder JM, Mrowietz U, Christophers E: Identification of different charged species of a human monocyte derived neutrophil activating peptide (MONAP). Biochem Biophys Res Commun 152:277-284, 1988a
44. Schröder JM, Mrowietz U, Christophers E: Purification and partial biochemical characterisation of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol 140:3534-3540, 1988b
45. Schröder JM, Gregory H, Young J, Christophers E: Neutrophil-activating proteins in psoriasis. J Invest Dermatol 98:241-247, 1992
46. Sedgwick JB, Bergstresser PR, Hurd ER: Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol 74:81-84, 1980
47. Springer T: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314, 1994
48. Sundberg JG, Boggess D, Sundberg BA, Beamer WG, Shultz LD: Epidermal dendritic cell populations in the flaky skin mouse mutant. Immunol Invest 22:389-401, 1993
49. Sundberg JP, Boggess D, Schultz LD, Beamer WG: The flaky skin (fsn) mutation, chromosome? In Sundberg JD (ed). Handbook of Mouse Mutations with Skin and Hair Abnormalities. Boca Raton, FL: CRC Press, 1994, pp. 253-268.
50. Sundberg JP, France M, Boggess D, Sundberg BA, Jenson AB, Beamer WG, Schultz LD: Development and progression of psoriasiform dermatitis and systemic lesions in the flaky skin (fsn) mouse mutation. Pathobiology 65:261-286, 1997
51. Takahashi H, Nukiwa T, Basset P, Crystal RG: Myelomonocytic cell lineage expression of the neutrophil elastase gene. J Biol Chem 263:2543-2547, 1988
52. Takematsu H, Tagami H: Granulocyte macrophage colony-stimulating factor in psoriasis. Dermatologica 181:16-20, 1990
53. Tepper RI, Coffman RL, Leder P: An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548-551, 1992
54. Thelen M, Peveri P, Kernen P, von Tsarner V, Waltz A, Baggiolini M: Mechanisms of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 2:2702-2706, 1988
55. Wahba A, Cohen HA, Bar-Eli M, Gallily R: Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris. J Invest Dermatol 71:186-188, 1978
56. Wasik F, Jedrzejak J, Miklaszewska M: Granulocyte pyruvate kinase in psoriasis vulgaris and psoriasis arthropathica. Br J Dermatol 116:9-14, 1987
57. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283-290, 1971